Le Lézard
Classified in: Science and technology, Business, Covid-19 virus
Subjects: EARNINGS, Conference Call, Webcast

SelectQuote, Inc. Reports Third Quarter 2024 Results


SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the third quarter of fiscal year 2024 of $376.4 million, compared to consolidated revenue for the third quarter of fiscal year 2023 of $299.4 million. Consolidated net income for the third quarter of fiscal year 2024 was $8.6 million, compared to consolidated net income for the third quarter of fiscal year 2023 of $9.3 million. Finally, consolidated Adjusted EBITDA* for the third quarter of fiscal year 2024 was $46.6 million, compared to consolidated Adjusted EBITDA* for the third quarter of fiscal year 2023 of $44.0 million.

Chief Executive Officer Tim Danker commented, "SelectQuote outperformed our own expectations for the 9th consecutive quarter, and the company has never been better positioned to drive shareholder value. We firmly believe SelectQuote can amplify the strong operating results achieved over the past two years since our foundational strategic redesign."

"Our Senior business completed another highly successful Medicare Advantage busy season in the quarter, which produced stable and attractive economics across both policy growth, LTV expansion, and operating efficiency. The segment's core tenured agents helped over 185,000 Americans find the right Medicare Advantage policy and did so with strong overall cost per policy and efficient close rates, which drove a Senior Adjusted EBITDA margin above 30% in one of our highest open enrollment period (OEP) quarters for revenue in company history. The success in our Senior business also enhanced the continued expansion of our Healthcare Services business, which saw SelectRx grow by over 12,000 members, significantly exceeding our original outlook. Overall, our holistic healthcare platform created new customers at a highly efficient revenue to customer acquisition cost of over 4x, which will drive significant Adjusted EBITDA contribution as Healthcare Services continues to scale."

Mr. Danker concluded, "The teams at SelectQuote and our leadership are energized about the successes experienced year-to-date. We have conviction that 2024 will prove to be an inflection point in our company's history, and SelectQuote is poised to leverage our unique healthcare platform to drive attractive returns for our shareholders in the quarters and years ahead."

Segment Results

We currently report on four segments: 1) Senior, 2) Healthcare Services, 3) Life, and 4) Auto & Home. The performance measures of the segments include total revenue, Adjusted EBITDA,* and Adjusted EBITDA Margin.* Costs of revenue, cost of goods sold-pharmacy revenue, marketing and advertising, selling, general, and administrative, and technical development operating expenses that are directly attributable to a segment are reported within the applicable segment. Indirect costs of revenue, marketing and advertising, selling, general, and administrative, and technical development operating expenses are allocated to each segment based on varying metrics such as headcount. Adjusted EBITDA is calculated as total revenue for the applicable segment less direct and allocated costs of revenue, cost of goods sold, marketing and advertising, technical development, and selling, general, and administrative operating costs and expenses, excluding depreciation and amortization expense; gain or loss on disposal of property, equipment, and software; share-based compensation expense; and non-recurring expenses such as severance payments and transaction costs.

Senior

Financial Results

The following table provides the financial results for the Senior segment for the periods presented:

 

Three Months Ended March 31,

 

 

 

Nine Months Ended March 31,

 

 

(in thousands)

2024

 

2023

 

% Change

 

2024

 

2023

 

% Change

Revenue

$

204,259

 

 

$

185,200

 

 

10

%

 

$

541,705

 

 

$

486,541

 

 

11

%

Adjusted EBITDA*

 

61,494

 

 

 

59,166

 

 

4

%

 

 

138,871

 

 

 

138,933

 

 

?

%

Adjusted EBITDA Margin*

 

30

%

 

 

32

%

 

 

 

 

26

%

 

 

29

%

 

 

Operating Metrics

Submitted Policies

Submitted policies are counted when an individual completes an application with our licensed agent and provides authorization to the agent to submit the application to the insurance carrier partner. The applicant may have additional actions to take before the application will be reviewed by the insurance carrier.

The following table shows the number of submitted policies for the periods presented:

 

Three Months Ended March 31,

 

 

 

Nine Months Ended March 31,

 

 

 

2024

 

2023

 

% Change

 

2024

 

2023

 

% Change

Medicare Advantage

226,692

 

196,372

 

15

%

 

602,936

 

538,247

 

12

%

Medicare Supplement

650

 

675

 

(4

)%

 

2,334

 

2,905

 

(20

)%

Dental, Vision and Hearing

16,588

 

21,175

 

(22

)%

 

48,892

 

59,513

 

(18

)%

Prescription Drug Plan

665

 

416

 

60

%

 

2,696

 

2,082

 

29

%

Other

774

 

1,864

 

(58

)%

 

3,724

 

5,402

 

(31

)%

Total

245,369

 

220,502

 

11

%

 

660,582

 

608,149

 

9

%

*See "Non-GAAP Financial Measures" below.

Approved Policies

Approved policies represents the number of submitted policies that were approved by our insurance carrier partners for the identified product during the indicated period. Not all approved policies will go in force.

The following table shows the number of approved policies for the periods presented:

 

Three Months Ended March 31,

 

 

 

Nine Months Ended March 31,

 

 

 

2024

 

2023

 

% Change

 

2024

 

2023

 

% Change

Medicare Advantage

185,716

 

165,530

 

12

%

 

517,973

 

467,540

 

11

%

Medicare Supplement

445

 

557

 

(20

)%

 

1,578

 

2,184

 

(28

)%

Dental, Vision and Hearing

14,042

 

16,968

 

(17

)%

 

41,474

 

47,940

 

(13

)%

Prescription Drug Plan

1,114

 

521

 

114

%

 

2,684

 

1,794

 

50

%

Other

789

 

1,029

 

(23

)%

 

2,834

 

3,932

 

(28

)%

Total

202,106

 

184,605

 

9

%

 

566,543

 

523,390

 

8

%

Lifetime Value of Commissions per Approved Policy

Lifetime value of commissions per approved policy represents commissions estimated to be collected over the estimated life of an approved policy based on multiple factors, including but not limited to, contracted commission rates, carrier mix and expected policy persistency with applied constraints. The lifetime value of commissions per approved policy is equal to the sum of the commission revenue due upon the initial sale of a policy, and when applicable, an estimate of future renewal commissions.

The following table shows the lifetime value of commissions per approved policy for the periods presented:

 

Three Months Ended March 31,

 

 

 

Nine Months Ended March 31,

 

 

(dollars per policy):

2024

 

2023

 

% Change

 

2024

 

2023

 

% Change

Medicare Advantage

$

995

 

$

965

 

3

%

 

$

923

 

 

$

888

 

4

%

Medicare Supplement

 

1,271

 

 

871

 

46

%

 

 

1,108

 

 

 

994

 

11

%

Dental, Vision and Hearing

 

101

 

 

91

 

11

%

 

 

100

 

 

 

95

 

5

%

Prescription Drug Plan

 

237

 

 

194

 

22

%

 

 

237

 

 

 

211

 

12

%

Other

 

36

 

 

123

 

(71

)%

 

 

(3

)

 

 

100

 

(103

)%

Healthcare Services

Financial Results

The following table provides the financial results for the Healthcare Services segment for the periods presented:

 

Three Months Ended March 31,

 

 

 

Nine Months Ended March 31,

 

 

(in thousands)

2024

 

2023

 

% Change

 

2024

 

2023

 

% Change

Revenue

$

124,207

 

 

$

70,725

 

 

76

%

 

$

333,284

 

 

$

169,270

 

 

97

%

Adjusted EBITDA*

 

1,609

 

 

 

(3,366

)

 

148

%

 

 

6,911

 

 

 

(24,456

)

 

128

%

Adjusted EBITDA Margin*

 

1

%

 

 

(5

)%

 

 

 

 

2

%

 

 

(14

)%

 

 

*See "Non-GAAP Financial Measures" below.

Operating Metrics

Total Members

The total number of SelectRx members represents the amount of customers to which an order has been shipped, as this is the primary key driver of revenue for Healthcare Services.

The following table shows the total number of SelectRx members for the date presented:

 

 

March 31, 2024

 

March 31, 2023

Total SelectRx Members

 

75,074

 

44,993

Prescriptions Per Day

Prescriptions per day represents the total average prescriptions shipped per business day, as this is a primary key driver of revenue for Healthcare Services.

The following table shows the prescriptions shipped per day for the periods presented:

 

 

Three Months Ended March 31,

 

Nine Months Ended March 31,

 

 

2024

 

2023

 

2024

 

2023

Prescriptions Per Day

 

20,216

 

11,737

 

17,582

 

9,753

Combined Senior and Healthcare Services - Consumer Per Unit Economics

The opportunity to leverage our existing database and distribution model to improve access to healthcare services for our consumers has created a need for us to review our key metrics related to our per unit economics. As we think about the revenue and expenses for Healthcare Services, we note that they are derived from the marketing acquisition costs associated with the sale of an MA or MS policy, some of which costs are allocated directly to Healthcare Services, and therefore determined that our per unit economics measure should include components from both Senior and Healthcare Services. See details of revenue and expense items included in the calculation below.

Combined Senior and Healthcare Services consumer per unit economics represents total MA and MS commissions; other product commissions; other revenues, including revenues from Healthcare Services; and operating expenses associated with Senior and Healthcare Services, each shown per number of approved MA and MS policies over a given time period. Management assesses the business on a per-unit basis to help ensure that the revenue opportunity associated with a successful policy sale is attractive relative to the marketing acquisition cost. Because not all acquired leads result in a successful policy sale, all per-policy metrics are based on approved policies, which is the measure that triggers revenue recognition.

The MA and MS commission per MA/MS policy represents the LTV for policies sold in the period. Other commission per MA/MS policy represents the LTV for other products sold in the period, including DVH prescription drug plan, and other products, which management views as additional commission revenue on our agents' core function of MA/MS policy sales. Pharmacy revenue per MA/MS policy represents revenue from SelectRx, and other revenue per MA/MS policy represents revenue from Population Health, production bonuses, marketing development funds, lead generation revenue, and adjustments from the Company's reassessment of its cohorts' transaction prices. Total operating expenses per MA/MS policy represents all of the operating expenses within Senior and Healthcare Services. The revenue to customer acquisition cost ("CAC") multiple represents total revenue as a multiple of total marketing acquisition costs, which represents the direct costs of acquiring leads. These costs are included in marketing and advertising expense within the total operating expenses per MA/MS policy.

The following table shows combined Senior and Healthcare Services consumer per unit economics for the periods presented. Based on the seasonality of Senior and the fluctuations between quarters, we believe that the most relevant view of per unit economics is on a rolling 12-month basis. All per MA/MS policy metrics below are based on the sum of approved MA/MS policies, as both products have similar commission profiles.

 

Twelve Months Ended March 31,

(dollars per approved policy):

2024

 

2023

Medicare Advantage and Medicare Supplement approved policies

 

630,013

 

 

 

586,238

 

Medicare Advantage and Medicare Supplement commission per MA/MS policy

$

907

 

 

$

886

 

Other commission per MA/MS policy

 

10

 

 

 

15

 

Pharmacy revenue per MA/MS policy

 

641

 

 

 

320

 

Other revenue per MA/MS policy

 

126

 

 

 

66

 

Total revenue per MA/MS policy

 

1,684

 

 

 

1,287

 

Total operating expenses per MA/MS policy

 

(1,425

)

 

 

(1,167

)

Adjusted EBITDA per MA/MS policy (1)

$

259

 

 

$

120

 

Adjusted EBITDA Margin per MA/MS policy (1)

 

15

%

 

 

9

%

Revenue/CAC multiple

4.2

X

 

3.5

X

(1) These financial measures are not calculated in accordance with GAAP. See "Management's Discussion and Analysis of Financial Condition and Results of Operations?Non-GAAP Financial Measures" in the Company's Quarterly Report on Form 10-Q for information regarding our use of these non-GAAP financial measures and a reconciliation of such measures to their nearest comparable financial measures calculated and presented in accordance with GAAP.

Total revenue per MA/MS policy increased 31% for the twelve months ended March 31, 2024, compared to the twelve months ended March 31, 2023, primarily due to the increase in pharmacy revenue. Total operating expenses per MA/MS policy increased 22% for the twelve months ended March 31, 2024, compared to the twelve months ended March 31, 2023, primarily driven by increase in cost of goods sold-pharmacy revenue for SelectRx due to the growth of the business.

Life

Financial Results

The following table provides the financial results for the Life segment for the periods presented:

 

Three Months Ended March 31,

 

 

 

Nine Months Ended March 31,

 

 

(in thousands)

2024

 

2023

 

% Change

 

2024

 

2023

 

% Change

Revenue

$

40,686

 

 

$

36,950

 

 

10

%

 

$

115,855

 

 

$

107,780

 

 

7

%

Adjusted EBITDA*

 

3,138

 

 

 

5,303

 

 

(41

)%

 

 

12,945

 

 

 

16,371

 

 

(21

)%

Adjusted EBITDA Margin*

 

8

%

 

 

14

%

 

 

 

 

11

%

 

 

15

%

 

 

Operating Metrics

Life premium represents the total premium value for all policies that were approved by the relevant insurance carrier partner and for which the policy document was sent to the policyholder and payment information was received by the relevant insurance carrier partner during the indicated period. Because our commissions are earned based on a percentage of total premium, total premium volume for a given period is the key driver of revenue for our Life segment.

*See "Non-GAAP Financial Measures" below.

The following table shows term and final expense premiums for the periods presented:

 

Three Months Ended March 31,

 

 

 

Nine Months Ended March 31,

 

 

(in thousands)

2024

 

2023

 

% Change

 

2024

 

2023

 

% Change

Term Premiums

$

16,788

 

$

17,512

 

(4

)%

 

$

52,376

 

$

48,433

 

8

%

Final Expense Premiums

 

23,724

 

 

19,308

 

23

%

 

 

62,811

 

 

58,766

 

7

%

Total

$

40,512

 

$

36,820

 

10

%

 

 

115,187

 

 

107,199

 

7

%

Auto & Home

Financial Results

The following table provides the financial results for the Auto & Home segment for the periods presented:

 

Three Months Ended March 31,

 

 

 

Nine Months Ended March 31,

 

 

(in thousands)

2024

 

2023

 

% Change

 

2024

 

2023

 

% Change

Revenue

$

9,134

 

 

$

8,238

 

 

11

%

 

$

28,649

 

 

$

23,128

 

 

24

%

Adjusted EBITDA*

 

3,609

 

 

 

2,591

 

 

39

%

 

 

11,654

 

 

 

7,315

 

 

59

%

Adjusted EBITDA Margin*

 

40

%

 

 

31

%

 

 

 

 

41

%

 

 

32

%

 

 

Operating Metrics

Auto & Home premium represents the total premium value of all new policies that were approved by our insurance carrier partners during the indicated period. Because our commissions are earned based on a percentage of total premium, total premium volume for a given period is the key driver of revenue for our Auto & Home segment.

The following table shows premiums for the periods presented:

 

Three Months Ended March 31,

 

 

 

Nine Months Ended March 31,

 

 

(in thousands):

2024

 

2023

 

% Change

 

2024

 

2023

 

% Change

Premiums

$

14,180

 

$

12,828

 

11

%

 

$

42,746

 

$

36,456

 

17

%

Amendment to Credit Agreement

On May 8, 2024, the Company and its lenders agreed to amend the Company's credit agreement to extend the maturity date with respect to $683.8 million of extended term loans from February 15, 2025 to May 15, 2025. The amendment also provides for a minimum asset coverage ratio and minimum liquidity requirements for the extension period. Additional information regarding the amendment will be included in the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2024.

Earnings Conference Call

SelectQuote, Inc. will host a conference call with the investment community today, Thursday, May 9, 2024, beginning at 9:00 a.m. ET. To register for this conference call, please use this link: https://www.netroadshow.com/events/login?show=2a79382d&confId=63927. After registering, a confirmation will be sent via email, including dial-in details and unique conference call codes for entry. Registration is open through the live call, but to ensure you are connected for the full call we suggest registering at least 10 minutes before the start of the call. The event will also be webcasted live via our investor relations website https://ir.selectquote.com/investor-home/default.aspx.

*See "Non-GAAP Financial Measures" below.

Non-GAAP Financial Measures

This release includes certain non-GAAP financial measures intended to supplement, not substitute for, comparable GAAP measures. To supplement our financial statements presented in accordance with GAAP and to provide investors with additional information regarding our GAAP financial results, we have presented in this release Adjusted EBITDA and Adjusted EBITDA Margin, which are non-GAAP financial measures. These non-GAAP financial measures are not based on any standardized methodology prescribed by GAAP and are not necessarily comparable to similarly titled measures presented by other companies. We define Adjusted EBITDA as income (loss) before interest expense, income tax expense (benefit), depreciation and amortization, and certain add-backs for non-cash or non-recurring expenses, including restructuring and share-based compensation expenses. The most directly comparable GAAP measure is net income (loss). We define Adjusted EBITDA Margin as Adjusted EBITDA divided by revenue. The most directly comparable GAAP measure is net income margin. We monitor and have presented in this release Adjusted EBITDA and Adjusted EBITDA Margin because they are key measures used by our management and Board of Directors to understand and evaluate our operating performance, to establish budgets and to develop operational goals for managing our business. In particular, we believe that excluding the impact of these expenses in calculating Adjusted EBITDA can provide a useful measure for period-to-period comparisons of our core operating performance.

We believe that these non-GAAP financial measures help identify underlying trends in our business that could otherwise be masked by the effect of the expenses that we exclude in the calculations of these non-GAAP financial measures. Accordingly, we believe these financial measures provide useful information to investors and others in understanding and evaluating our operating results, enhancing the overall understanding of our past performance and future prospects. Reconciliations of the differences between the non-GAAP financial measures included herein and their most directly comparable GAAP financial measures are set forth below beginning on page 12.

Forward Looking Statements

This release contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "should," "could," "predict," "potential," "believe," "will likely result," "expect," "continue," "will," "anticipate," "seek," "estimate," "intend," "plan," "projection," "would" and "outlook," or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. These forward-looking statements are not historical facts, and are based on current expectations, estimates, and projections about our industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements.

There are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the following: the impacts of the COVID-19 pandemic and any other public health events, our reliance on a limited number of insurance carrier partners and any potential termination of those relationships or failure to develop new relationships; existing and future laws and regulations affecting the health insurance market; changes in health insurance products offered by our insurance carrier partners and the health insurance market generally; insurance carriers offering products and services directly to consumers; changes to commissions paid by insurance carriers and underwriting practices; competition with brokers, including exclusively online brokers and carriers who opt to sell policies directly to consumers; competition from government-run health insurance exchanges; developments in the U.S. health insurance system; our dependence on revenue from carriers in our senior segment and downturns in the senior health as well as life, automotive and home insurance industries; our ability to develop new offerings and penetrate new vertical markets; risks from third-party products; failure to enroll individuals during the Medicare annual enrollment period; our ability to attract, integrate and retain qualified personnel; our dependence on lead providers and ability to compete for leads; failure to obtain and/or convert sales leads to actual sales of insurance policies; access to data from consumers and insurance carriers; accuracy of information provided from and to consumers during the insurance shopping process; cost-effective advertisement through internet search engines; ability to contact consumers and market products by telephone; global economic conditions, including inflation; disruption to operations as a result of future acquisitions; significant estimates and assumptions in the preparation of our financial statements; impairment of goodwill; potential litigation and other legal proceedings or inquiries; our existing and future indebtedness; our ability to maintain compliance with our debt covenants and meet our scheduled repayment obligations under our debt arrangements; our ability to access additional capital on acceptable terms; failure to protect our intellectual property and our brand; fluctuations in our financial results caused by seasonality; accuracy and timeliness of commissions reports from insurance carriers; timing of insurance carriers' approval and payment practices; factors that impact our estimate of the constrained lifetime value of commissions per policyholder; changes in accounting rules, tax legislation and other legislation; disruptions or failures of our technological infrastructure and platform; failure to maintain relationships with third-party service providers; cybersecurity breaches or other attacks involving our systems or those of our insurance carrier partners or third-party service providers; our ability to protect consumer information and other data; failure to market and sell Medicare plans effectively or in compliance with laws; and other factors related to our pharmacy business, including manufacturing or supply chain disruptions, access to and demand for prescription drugs, and regulatory changes or other industry developments that may affect our pharmacy operations. For a further discussion of these and other risk factors that could impact our future results and performance, see the section entitled "Risk Factors" in the most recent Annual Report on Form 10-K and subsequent periodic reports filed by us with the Securities and Exchange Commission. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

About SelectQuote:

Founded in 1985, SelectQuote (NYSE: SLQT) provides solutions that help consumers protect their most valuable assets: their families, health, and property. The company pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote's success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads.

With an ecosystem offering high touchpoints for consumers across insurance, medicare, pharmacy, and value-based care, the company now has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote Senior serves the needs of a demographic that sees around 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. SelectQuote Healthcare Services is comprised of the SelectRx Pharmacy, a Patient-Centered Pharmacy Hometm (PCPH) accredited pharmacy, and Population Health, which proactively connects consumers with a wide breadth of healthcare services supporting their needs..

 

SELECTQUOTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands)

 

 

March 31, 2024

 

June 30, 2023

ASSETS

 

 

 

CURRENT ASSETS:

 

 

 

Cash and cash equivalents

$

37,808

 

 

$

83,156

 

Accounts receivable, net of allowances of $6.5 million and $2.7 million, respectively

 

253,083

 

 

 

154,565

 

Commissions receivable-current

 

69,165

 

 

 

111,148

 

Other current assets

 

24,115

 

 

 

14,355

 

Total current assets

 

384,171

 

 

 

363,224

 

COMMISSIONS RECEIVABLE?Net

 

763,958

 

 

 

729,350

 

PROPERTY AND EQUIPMENT?Net

 

22,536

 

 

 

27,452

 

SOFTWARE?Net

 

13,952

 

 

 

14,740

 

OPERATING LEASE RIGHT-OF-USE ASSETS

 

19,341

 

 

 

23,563

 

INTANGIBLE ASSETS?Net

 

7,926

 

 

 

10,200

 

GOODWILL

 

29,136

 

 

 

29,136

 

OTHER ASSETS

 

4,119

 

 

 

21,586

 

TOTAL ASSETS

$

1,245,139

 

 

$

1,219,251

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

CURRENT LIABILITIES:

 

 

 

Accounts payable

$

61,168

 

 

$

27,577

 

Accrued expenses

 

21,058

 

 

 

16,993

 

Accrued compensation and benefits

 

57,483

 

 

 

49,966

 

Operating lease liabilities?current

 

4,663

 

 

 

5,175

 

Current portion of long-term debt

 

37,717

 

 

 

33,883

 

Contract liabilities

 

3,655

 

 

 

1,691

 

Other current liabilities

 

4,227

 

 

 

1,972

 

Total current liabilities

 

189,971

 

 

137,257

 

LONG-TERM DEBT, NET?less current portion

 

648,331

 

 

 

664,625

 

DEFERRED INCOME TAXES

 

35,057

 

 

 

39,581

 

OPERATING LEASE LIABILITIES

 

22,326

 

 

 

27,892

 

OTHER LIABILITIES

 

2,649

 

 

 

2,926

 

Total liabilities

 

898,334

 

 

 

872,281

 

 

 

 

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

SHAREHOLDERS' EQUITY:

 

 

 

Common stock, $0.01 par value

 

1,692

 

 

 

1,669

 

Additional paid-in capital

 

577,389

 

 

 

567,266

 

Accumulated deficit

 

(238,752

)

 

 

(235,644

)

Accumulated other comprehensive income

 

6,476

 

 

 

13,679

 

Total shareholders' equity

 

346,805

 

 

 

346,970

 

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

$

1,245,139

 

 

$

1,219,251

 

SELECTQUOTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)

(In thousands)

 

 

Three Months Ended March 31,

 

Nine Months Ended March 31,

 

2024

 

2023

 

2024

 

2023

REVENUE:

 

 

 

 

 

 

 

Commission

$

230,763

 

 

$

197,258

 

 

$

611,744

 

 

 

533,627

 

Pharmacy

 

120,282

 

 

 

66,948

 

 

 

323,865

 

 

 

159,641

 

Other

 

25,355

 

 

 

35,192

 

 

 

78,958

 

 

 

87,802

 

Total revenue

 

376,400

 

 

 

299,398

 

 

 

1,014,567

 

 

 

781,070

 

 

 

 

 

 

 

 

 

OPERATING COSTS AND EXPENSES:

 

 

 

 

 

 

 

Cost of revenue

 

84,315

 

 

 

79,186

 

 

 

254,250

 

 

 

235,827

 

Cost of goods sold?pharmacy revenue

 

106,172

 

 

 

62,302

 

 

 

284,360

 

 

 

154,753

 

Marketing and advertising

 

109,276

 

 

 

90,205

 

 

 

288,676

 

 

 

237,724

 

Selling, general, and administrative

 

34,971

 

 

 

27,544

 

 

 

97,049

 

 

 

86,662

 

Technical development

 

8,604

 

 

 

6,434

 

 

 

24,291

 

 

 

18,860

 

Total operating costs and expenses

 

343,338

 

 

 

265,671

 

 

 

948,626

 

 

 

733,826

 

 

 

 

 

 

 

 

 

INCOME FROM OPERATIONS

 

33,062

 

 

 

33,727

 

 

 

65,941

 

 

 

47,244

 

 

 

 

 

 

 

 

 

INTEREST EXPENSE, NET

 

(24,330

)

 

 

(21,105

)

 

 

(70,141

)

 

 

(58,885

)

OTHER INCOME (EXPENSE,) NET

 

(12

)

 

 

(206

)

 

 

(51

)

 

 

(118

)

INCOME (LOSS) BEFORE INCOME TAX EXPENSE (BENEFIT)

 

8,720

 

 

 

12,416

 

 

 

(4,251

)

 

 

(11,759

)

INCOME TAX EXPENSE (BENEFIT)

 

169

 

 

 

3,152

 

 

 

(1,143

)

 

 

(1,053

)

 

 

 

 

 

 

 

 

NET INCOME (LOSS)

$

8,551

 

 

$

9,264

 

 

$

(3,108

)

 

 

(10,706

)

 

 

 

 

 

 

 

 

NET INCOME (LOSS) PER SHARE:

 

 

 

 

 

 

 

Basic

$

0.05

 

 

$

0.06

 

 

$

(0.02

)

 

$

(0.06

)

Diluted

$

0.05

 

 

$

0.06

 

 

$

(0.02

)

 

$

(0.06

)

 

 

 

 

 

 

 

 

WEIGHTED-AVERAGE COMMON STOCK OUTSTANDING USED IN PER SHARE AMOUNTS:

 

 

 

 

 

 

 

Basic

 

169,070

 

 

 

166,543

 

 

 

168,291

 

 

 

165,951

 

Diluted

 

170,956

 

 

 

167,905

 

 

 

168,291

 

 

 

165,951

 

 

 

 

 

 

 

 

 

OTHER COMPREHENSIVE INCOME (LOSS) NET OF TAX:

 

 

 

 

 

 

 

Gain (loss) on cash flow hedge

 

(1,771

)

 

 

(2,661

)

 

 

(7,203

)

 

 

1,358

 

OTHER COMPREHENSIVE INCOME (LOSS)

 

(1,771

)

 

 

(2,661

)

 

 

(7,203

)

 

 

1,358

 

COMPREHENSIVE INCOME (LOSS)

$

6,780

 

 

$

6,603

 

 

$

(10,311

)

 

$

(9,348

)

SELECTQUOTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

 

Nine Months Ended March 31,

 

2024

 

2023

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

Net loss

$

(3,108

)

 

$

(10,706

)

Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:

 

 

 

Depreciation and amortization

 

18,591

 

 

 

21,087

 

Loss on disposal of property, equipment, and software

 

13

 

 

 

390

 

Share-based compensation expense

 

10,512

 

 

 

8,525

 

Deferred income taxes

 

(2,151

)

 

 

(1,416

)

Amortization of debt issuance costs and debt discount

 

4,863

 

 

 

6,250

 

Write-off of debt issuance costs

 

293

 

 

 

710

 

Accrued interest payable in kind

 

14,323

 

 

 

8,450

 

Non-cash lease expense

 

1,945

 

 

 

3,115

 

Changes in operating assets and liabilities:

 

 

 

Accounts receivable, net

 

(98,519

)

 

 

(62,738

)

Commissions receivable

 

7,375

 

 

 

17,092

 

Other assets

 

(2,620

)

 

 

3,166

 

Accounts payable and accrued expenses

 

36,073

 

 

 

6,440

 

Operating lease liabilities

 

(3,802

)

 

 

(4,331

)

Other liabilities

 

11,453

 

 

 

(8,869

)

Net cash used in operating activities

 

(4,759

)

 

 

(12,835

)

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

Purchases of property and equipment

 

(3,114

)

 

 

(1,056

)

Proceeds from sales of property and equipment

 

253

 

 

 

?

 

Purchases of software and capitalized software development costs

 

(6,065

)

 

 

(5,804

)

Net cash used in investing activities

 

(8,926

)

 

 

(6,860

)

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

Payments on Term Loans

 

(30,412

)

 

 

(17,833

)

Payments on other debt

 

(112

)

 

 

(123

)

Proceeds from common stock options exercised and employee stock purchase plan

 

8

 

 

 

1,187

 

Payments of tax withholdings related to net share settlement of equity awards

 

(374

)

 

 

(40

)

Payments of debt issuance costs

 

(773

)

 

 

(10,110

)

Payment of acquisition holdback

 

?

 

 

 

(2,335

)

Net cash used in financing activities

 

(31,663

)

 

 

(29,254

)

NET DECREASE IN CASH AND CASH EQUIVALENTS

 

(45,348

)

 

 

(48,949

)

CASH AND CASH EQUIVALENTS?Beginning of period

 

83,156

 

 

 

140,997

 

CASH AND CASH EQUIVALENTS?End of period

$

37,808

 

 

$

92,048

 

SELECTQUOTE, INC. AND SUBSIDIARIES

Net Income (Loss) to Adjusted EBITDA Reconciliation

(Unaudited)

 

 

Three Months Ended March 31, 2024

(in thousands)

Senior

 

Healthcare Services

 

Life

 

Auto & Home

 

Corp & Elims

 

Consolidated

Revenue

$

204,259

 

 

$

124,207

 

 

$

40,686

 

 

$

9,134

 

 

$

(1,886

)

 

$

376,400

 

Operating expenses

 

(142,765

)

 

 

(122,598

)

 

 

(37,548

)

 

 

(5,524

)

 

 

(21,355

)

 

 

(329,790

)

Other income (expense), net

 

?

 

 

 

?

 

 

 

?

 

 

 

(1

)

 

 

(11

)

 

 

(12

)

Adjusted EBITDA

$

61,494

 

 

$

1,609

 

 

$

3,138

 

 

$

3,609

 

 

$

(23,252

)

 

$

46,598

 

Share-based compensation expense

 

 

 

 

 

 

 

 

 

 

 

(3,515

)

Transaction costs

 

 

 

 

 

 

 

 

 

 

 

(3,325

)

Depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

(6,704

)

Loss on disposal of property, equipment, and software

 

 

 

 

 

 

 

 

 

 

 

(4

)

Interest expense, net

 

 

 

 

 

 

 

 

 

 

 

(24,330

)

Income tax expense

 

 

 

 

 

 

 

 

 

 

 

(169

)

Net income

 

 

 

 

 

 

 

 

 

 

$

8,551

 

 

Three Months Ended March 31, 2023

(in thousands)

Senior

 

Healthcare Services

 

Life

 

Auto & Home

 

Corp & Elims

 

Consolidated

Revenue

$

185,200

 

 

$

70,725

 

 

$

36,950

 

 

$

8,238

 

 

$

(1,715

)

 

$

299,398

 

Operating expenses

 

(126,034

)

 

 

(74,091

)

 

 

(31,446

)

 

 

(5,648

)

 

 

(17,947

)

 

 

(255,166

)

Other income (expense), net

 

?

 

 

 

?

 

 

 

(201

)

 

 

1

 

 

 

(6

)

 

 

(206

)

Adjusted EBITDA

$

59,166

 

 

$

(3,366

)

 

$

5,303

 

 

$

2,591

 

 

$

(19,668

)

 

$

44,026

 

Share-based compensation expense

 

 

 

 

 

 

 

 

 

 

 

(2,959

)

Transaction costs

 

 

 

 

 

 

 

 

 

 

 

(433

)

Depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

(7,098

)

Loss on disposal of property, equipment, and software

 

 

 

 

 

 

 

 

 

 

 

(15

)

Interest expense, net

 

 

 

 

 

 

 

 

 

 

 

(21,105

)

Income tax expense

 

 

 

 

 

 

 

 

 

 

 

(3,152

)

Net income

 

 

 

 

 

 

 

 

 

 

$

9,264

 

 

Nine Months Ended March 31, 2024

(in thousands)

Senior

 

Healthcare Services

 

Life

 

Auto & Home

 

Corp & Elims

 

Consolidated

Revenue

$

541,705

 

 

$

333,284

 

 

$

115,855

 

 

$

28,649

 

 

$

(4,926

)

 

$

1,014,567

 

Operating expenses

 

(402,834

)

 

 

(326,373

)

 

 

(102,910

)

 

 

(16,994

)

 

 

(62,770

)

 

 

(911,881

)

Other income (expense), net

 

?

 

 

 

?

 

 

 

?

 

 

 

(1

)

 

 

(50

)

 

 

(51

)

Adjusted EBITDA

$

138,871

 

 

$

6,911

 

 

$

12,945

 

 

$

11,654

 

 

$

(67,746

)

 

$

102,635

 

Share-based compensation expense

 

 

 

 

 

 

 

 

 

 

 

(10,512

)

Transaction costs

 

 

 

 

 

 

 

 

 

 

 

(7,629

)

Depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

(18,591

)

Loss on disposal of property, equipment, and software

 

 

 

 

 

 

 

 

 

 

 

(13

)

Interest expense, net

 

 

 

 

 

 

 

 

 

 

 

(70,141

)

Income tax benefit

 

 

 

 

 

 

 

 

 

 

 

1,143

 

Net loss

 

 

 

 

 

 

 

 

 

 

$

(3,108

)

 

Nine Months Ended March 31, 2023

(in thousands)

Senior

 

Healthcare Services

 

Life

 

Auto & Home

 

Corp & Elims

 

Consolidated

Revenue

$

486,541

 

 

$

169,270

 

 

$

107,780

 

 

$

23,128

 

 

$

(5,649

)

 

$

781,070

 

Operating expenses

 

(347,608

)

 

 

(193,726

)

 

 

(91,409

)

 

 

(15,812

)

 

 

(52,270

)

 

 

(700,825

)

Other income (expense), net

 

?

 

 

 

?

 

 

 

?

 

 

 

(1

)

 

 

(117

)

 

 

(118

)

Adjusted EBITDA

$

138,933

 

 

$

(24,456

)

 

$

16,371

 

 

$

7,315

 

 

$

(58,036

)

 

$

80,127

 

Share-based compensation expense

 

 

 

 

 

 

 

 

 

 

 

(8,525

)

Transaction costs

 

 

 

 

 

 

 

 

 

 

 

(3,003

)

Depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

(21,087

)

Loss on disposal of property, equipment, and software

 

 

 

 

 

 

 

 

 

 

 

(386

)

Interest expense, net

 

 

 

 

 

 

 

 

 

 

 

(58,885

)

Income tax benefit

 

 

 

 

 

 

 

 

 

 

 

1,053

 

Net loss

 

 

 

 

 

 

 

 

 

 

$

(10,706

)

SELECTQUOTE, INC. AND SUBSIDIARIES

Net Loss to Adjusted EBITDA Reconciliation

(Unaudited) 

 

Guidance net loss to Adjusted EBITDA reconciliation, year ending June 30, 2024:

 

(in thousands)

Range

Net loss

$

(34,000

)

 

$

(21,000

)

Income tax benefit

 

(12,000

)

 

 

(8,000

)

Interest expense, net

 

96,000

 

 

 

94,000

 

Depreciation and amortization

 

26,000

 

 

 

24,000

 

Share-based compensation expense

 

14,000

 

 

 

13,000

 

Non-recurring expenses

 

10,000

 

 

 

8,000

 

Adjusted EBITDA

$

100,000

 

 

$

110,000

 

 


These press releases may also interest you

21 jun 2024
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 5, 2024 to file lead plaintiff applications in a securities class action lawsuit against The...

21 jun 2024
The Prime Minister, Justin Trudeau, today issued the following statement on the passing of James K. Irving: "It is with sadness that I learned today of the passing of James K. Irving, a successful Canadian business leader and entrepreneur. "A proud...

21 jun 2024
TSX VENTURE COMPANIES NEX COMPANY BULLETIN V2024-1898 CHINA KELI ELECTRIC COMPANY LTD. ("ZKL.H")BULLETIN TYPE:  Reinstated for TradingBULLETIN DATE:  June 21, 2024NEX Company Further to the TSX Venture Exchange Bulletin dated January 9, 2023, the...

21 jun 2024
B2Gold Corp. ("B2Gold" or the "Company") is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held on Thursday, June 20, 2024. A total of 845,972,994 common shares were voted at the...

21 jun 2024
Global X Investments Canada Inc. ("Global X") is pleased to announce the distribution amounts per security (the "Distributions") for its exchange traded funds (the "ETFs"), for the period ending June 30, 2024, as indicated in the tables below. The...

21 jun 2024
The Minister of Diversity, Inclusion and Persons with Disabilities, the Honorable Kamal Khera, and the Minister for Women and Gender Equality and Youth, the Honorable Marci Ien, will be in Mississauga to announce investments in mental health support...



News published on and distributed by: